Insilico Medicine Leads Hong Kong Biotech IPO with AI Drug Discovery Prowess
December 30, 2025 — 19:00 CST
This Data Is Locked!
This area is available only to Subscribers.
Insilico Medicine, a clinical-stage drug discovery and development company driven by artificial intelligence (AI), has made history by being listed on the Hong Kong Stock... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals